The 2022 OncoAlert Colloquium Day 6: EONS Sessions
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
The 2022 OncoAlert Colloquium Day 5: GI Oncology
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
The 2022 OncoAlert Colloquium Day 2: GU Oncology
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer
Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML
Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery
Updates from TAILORx and RxPONDER: Implications for practice
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery